Q1 EPS Forecast for Nurix Therapeutics Increased by Analyst
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – Research analysts at HC Wainwright upped their Q1 2025 EPS estimates for shares of Nurix Therapeutics in a report released on Wednesday, April 2nd. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.60) for the quarter, up from their […]
